drugset / Trial / NCT00572234

Bupropion in the Treatment of Methamphetamine Dependence

NCT00572234

Completed 40 enrolled University of Nebraska
RandomizedParallel-groupOpen-labelTreatment

Summary

Methamphetamine dependence is a significant drug use disorder in the Midwest. While a number of psychosocial and pharmacological treatments have been studied, no specific treatments for methamphetamine have been identified. This study is a collaborative pre-clinical and clinical partnership examining bupropion in the treatment of methamphetamine dependence.

Timeline

Start
2007-08-31
Primary completion
2010-04-06
Completion
2011-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 150 mg